SurgePays (SURG) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

SURG Stock Forecast


SurgePays stock forecast is as follows: an average price target of $10.00 (represents a 513.50% upside from SURG’s last price of $1.63) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

SURG Price Target


The average price target for SurgePays (SURG) is $10.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 513.50% upside from SURG's last price of $1.63.

SURG Analyst Ratings


Buy

According to 2 Wall Street analysts, SurgePays's rating consensus is 'Buy'. The analyst rating breakdown for SURG stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

SurgePays Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 01, 2024Edward WooAscendiant$10.00$3.85159.74%513.50%
Row per page
Go to

The latest SurgePays stock forecast, released on Apr 01, 2024 by Edward Woo from Ascendiant, set a price target of $10.00, which represents a 159.74% increase from the stock price at the time of the forecast ($3.85), and a 513.50% increase from SURG last price ($1.63).

SurgePays Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$10.00
Last Closing Price$1.63$1.63$1.63
Upside/Downside-100.00%-100.00%513.50%

In the current month, the average price target of SurgePays stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SurgePays's last price of $1.63. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Apr 01, 2024AscendiantBuyBuyHold
Feb 28, 2022Maxim Group-BuyInitialise
Row per page
Go to

SurgePays's last stock rating was published by Ascendiant on Apr 01, 2024. The company gave SURG a "Buy" rating, the same as its previous rate.

SurgePays Financial Forecast


SurgePays Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
Revenue--------$32.32M$34.16M$35.89M$34.78M$36.23M$36.17M$28.01M$21.14M$14.16M
Avg Forecast$18.20M$16.95M$14.34M$9.11M$7.46M$5.88M$10.38M$25.27M$33.55M$37.83M$39.05M$36.50M$40.10M$33.48M$27.11M$22.11M$14.89M
High Forecast$18.20M$16.95M$14.34M$9.11M$7.46M$7.13M$10.38M$25.27M$35.04M$37.83M$39.05M$36.50M$40.10M$33.48M$27.11M$22.11M$14.89M
Low Forecast$18.20M$16.95M$14.34M$9.11M$7.46M$4.63M$10.38M$25.27M$32.11M$37.83M$39.05M$36.50M$40.10M$33.48M$27.11M$22.11M$14.89M
# Analysts11111211311111111
Surprise %--------0.96%0.90%0.92%0.95%0.90%1.08%1.03%0.96%0.95%

SurgePays's average Quarter revenue forecast for Mar 24 based on 1 analysts is $25.27M, with a low forecast of $25.27M, and a high forecast of $25.27M. SURG's average Quarter revenue forecast represents a -21.80% decrease compared to the company's last Quarter revenue of $32.32M (Dec 23).

SurgePays EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111211311111111
EBITDA--------$1.14M$7.09M$6.20M$5.01M$4.11M$-752.48K$-610.12K$-880.31K$-5.11M
Avg Forecast$-1.20M$-1.12M$-947.40K$-601.71K$-492.72K$-388.37K$-685.66K$-1.67M$-2.22M$-2.50M$-2.58M$-2.41M$-2.65M$-2.21M$-1.79M$-1.46M$-983.53K
High Forecast$-1.20M$-1.12M$-947.40K$-601.71K$-492.72K$-305.67K$-685.66K$-1.67M$-2.12M$-2.50M$-2.58M$-2.41M$-2.65M$-2.21M$-1.79M$-1.46M$-983.53K
Low Forecast$-1.20M$-1.12M$-947.40K$-601.71K$-492.72K$-471.08K$-685.66K$-1.67M$-2.31M$-2.50M$-2.58M$-2.41M$-2.65M$-2.21M$-1.79M$-1.46M$-983.53K
Surprise %---------0.52%-2.84%-2.40%-2.08%-1.55%0.34%0.34%0.60%5.19%

1 analysts predict SURG's average Quarter EBITDA for Mar 24 to be $-1.67M, with a high of $-1.67M and a low of $-1.67M. This is -246.05% lower than SurgePays's previous annual EBITDA (Dec 23) of $1.14M.

SurgePays Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111211311111111
Net Income--------$3.02M$7.08M$5.97M$4.55M$3.04M$-1.54M$-448.89K$-1.21M$-5.48M
Avg Forecast$1.36M$518.18K$-1.04M$-2.59M$-4.47M$-5.18M$-2.07M$2.91M$7.90M$5.54M$3.01M$-582.95K$-2.23M$5.64M$194.31K$-874.42K$777.26K
High Forecast$1.36M$518.18K$-1.04M$-2.59M$-4.47M$-4.71M$-2.07M$2.91M$9.83M$5.54M$3.01M$-582.95K$-2.23M$5.64M$194.31K$-874.42K$777.26K
Low Forecast$1.36M$518.18K$-1.04M$-2.59M$-4.47M$-5.65M$-2.07M$2.91M$5.40M$5.54M$3.01M$-582.95K$-2.23M$5.64M$194.31K$-874.42K$777.26K
Surprise %--------0.38%1.28%1.98%-7.80%-1.36%-0.27%-2.31%1.39%-7.06%

SurgePays's average Quarter net income forecast for Mar 24 is $2.91M, with a range of $2.91M to $2.91M. SURG's average Quarter net income forecast represents a -3.53% decrease compared to the company's last Quarter net income of $3.02M (Dec 23).

SurgePays SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111211311111111
SG&A--------$6.31M$3.39M$3.82M$2.72M$2.92M$2.93M$2.85M$3.51M$3.72M
Avg Forecast$3.93M$3.66M$3.10M$1.97M$1.61M$1.27M$2.24M$5.46M$7.25M$8.17M$8.43M$7.88M$8.66M$7.23M$5.85M$4.78M$3.21M
High Forecast$3.93M$3.66M$3.10M$1.97M$1.61M$1.54M$2.24M$5.46M$7.57M$8.17M$8.43M$7.88M$8.66M$7.23M$5.85M$4.78M$3.21M
Low Forecast$3.93M$3.66M$3.10M$1.97M$1.61M$999.13K$2.24M$5.46M$6.94M$8.17M$8.43M$7.88M$8.66M$7.23M$5.85M$4.78M$3.21M
Surprise %--------0.87%0.41%0.45%0.35%0.34%0.41%0.49%0.74%1.16%

SurgePays's average Quarter SG&A projection for Mar 24 is $5.46M, based on 1 Wall Street analysts, with a range of $5.46M to $5.46M. The forecast indicates a -13.49% fall compared to SURG last annual SG&A of $6.31M (Dec 23).

SurgePays EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts11111211311111111
EPS--------$0.21$0.50$0.42$0.32$0.07$-0.12$-0.04$-0.10$-0.04
Avg Forecast$0.07$0.03$-0.05$-0.13$-0.23$-0.27$-0.11$0.15$0.41$0.28$0.15$-0.03$-0.12$0.29$0.01$-0.04$0.04
High Forecast$0.07$0.03$-0.05$-0.13$-0.23$-0.24$-0.11$0.15$0.51$0.28$0.15$-0.03$-0.12$0.29$0.01$-0.04$0.04
Low Forecast$0.07$0.03$-0.05$-0.13$-0.23$-0.29$-0.11$0.15$0.28$0.28$0.15$-0.03$-0.12$0.29$0.01$-0.04$0.04
Surprise %--------0.52%1.75%2.71%-10.67%-0.60%-0.41%-3.66%2.22%-0.89%

According to 1 Wall Street analysts, SurgePays's projected average Quarter EPS for Mar 24 is $0.15, with a low estimate of $0.15 and a high estimate of $0.15. This represents a -28.57% decrease compared to SURG previous annual EPS of $0.21 (Dec 23).

SurgePays Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
EXFYExpensify$1.84$13.75647.28%Buy
SURGSurgePays$1.63$10.00513.50%Buy
VSVersus Systems$1.95$3.0053.85%Buy
ENVEnvestnet$62.79$67.868.07%Hold
CWANClearwater Analytics$26.31$26.330.08%Buy
DSPViant$11.95$8.83-26.11%Buy

SURG Forecast FAQ


Yes, according to 2 Wall Street analysts, SurgePays (SURG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of SURG's total ratings.

SurgePays (SURG) average price target is $10 with a range of $10 to $10, implying a 513.50% from its last price of $1.63. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for SURG stock, the company can go up by 513.50% (from the last price of $1.63 to the average price target of $10), up by 513.50% based on the highest stock price target, and up by 513.50% based on the lowest stock price target.

SURG's average twelve months analyst stock price target of $10 supports the claim that SurgePays can reach $2 in the near future.

SurgePays's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $48.99M (high $50.24M, low $47.74M), average EBITDA is $-3.237M (high $-3.154M, low $-3.319M), average net income is $-8.809M (high $-8.338M, low $-9.28M), average SG&A $10.58M (high $10.85M, low $10.31M), and average EPS is $-0.453 (high $-0.429, low $-0.478). SURG's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $58.6M (high $58.6M, low $58.6M), average EBITDA is $-3.872M (high $-3.872M, low $-3.872M), average net income is $-1.749M (high $-1.749M, low $-1.749M), average SG&A $12.65M (high $12.65M, low $12.65M), and average EPS is $-0.09 (high $-0.09, low $-0.09).

Based on SurgePays's last annual report (Dec 2023), the company's revenue was $137.14M, which missed the average analysts forecast of $146.93M by -6.66%. Apple's EBITDA was $19.97M, missing the average prediction of $-9.708M by -305.75%. The company's net income was $20.62M, beating the average estimation of $15.87M by 29.92%. Apple's SG&A was $15.71M, missing the average forecast of $31.73M by -50.48%. Lastly, the company's EPS was $1.38, beating the average prediction of $0.817 by 68.98%. In terms of the last quarterly report (Dec 2023), SurgePays's revenue was $32.32M, missing the average analysts' forecast of $33.55M by -3.68%. The company's EBITDA was $1.14M, missing the average prediction of $-2.217M by -151.57%. SurgePays's net income was $3.02M, missing the average estimation of $7.9M by -61.77%. The company's SG&A was $6.31M, missing the average forecast of $7.25M by -12.93%. Lastly, the company's EPS was $0.21, missing the average prediction of $0.407 by -48.36%